February 9, 2024 — MIVI Neuroscience, Inc. announced the primary endpoint results of its EvaQ Trial, a prospective ...
February 9, 2024 — Physicians in the Smidt Heart Institute at Cedars-Sinai have achieved two significant firsts ...
February 9, 2024 — BIOTRONIK introduced the Micro Rx catheter, a novel rapid exchange microcatheter developed to easily ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
February 8, 2024 — The American Heart Association (AHA), currently celebrating its centennial year, announced that it is ...
February 8, 2024 — The latest late-breaking science from the second day of the American Stroke Association’s ...
February 7, 2024 — According to results from a multi-center trial in the United States, called Zero Degree Head ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
February 7, 2024 — Medtronic announced new cost-effectiveness data from the STROKE AF clinical study, which showed that ...
February 7, 2024 — Combining brain stimulation with intense physical rehabilitation helped stroke survivors recover ...
February 7, 2024 — The Consumer Technology Association (CTA) and the American College of Cardiology (ACC) are announcing ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
February 7, 2024 — Researchers presenting preliminary late-breaking science presented on the first day of the American ...
February 7, 2024 — Eleven scientists leading the way in stroke research will be recognized during the American Stroke ...
February 6, 2024 — A recent study co-authored by Dr. Matthew Segar, a third-year cardiovascular disease fellow at The ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
February 6, 2024 — BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and ...
February 6, 2024 — Cortex announced the initiation of its RESOLVE-AF trial (NCT05883631), a study formally launched in ...
February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 ...